Immunion

Novavax, szczepionka
30-12-2021

Nuvaxovid: The EU authorises its fifth COVID-19 vaccine, but lacks data on its efficiency against the Omicron variant

The European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine Nuvaxovid, which is already the fifth vaccine approved for use in the EU.
szczepionka, szczepienie
28-12-2021

Countries mull mandatory COVID-19 vaccination, but worry about ethics and potential results

Numerous European governments are considering following Austria's example, but fear of increasing vaccine hesitancy, political losses and accusations of violating human rights.
pandemia-covid-19-koronawirus-EMA-komisja-europejska-Nuvaxovid -novavax
Instytucje UE 21-12-2021

Nuvaxovid: Piąta szczepionka przeciw COVID-19 dopuszczona w UE

Skuteczność szczepionki dla Nuvaxovidu wynosi około 90 proc.
COVID-19-pandemia-vaccination campaign-Israel-Omikron-mRNA-EMA-Africa-fauci
10-12-2021

Booster vaccination speeds up. Data from Israel prove its effectiveness

The example of Israel shows that a third dose enhances significantly the level of protection from COVID-19.
szczepienia, szczepionka
30-11-2021

Polio: A forgotten disease returns. Is a new pandemic a real threat?

Poliomyelitis is developing new cases in Asia, Africa and even Europe. How the once practically eradicated disease become a danger again?
Zachód przyspiesza z podawaniem trzeciej dawki szczepionki na koronawirusa (Photo by Towfiqu barbhuiya on Unsplash )
29-11-2021

Podawanie trzeciej dawki szczepionki na koronawirusa przyspiesza. Dane z Izraela pokazują, że szczepienie przypominające działa

Świat zachodni przyspiesza podawanie przypominającej dawki szczepionki na koronawirusa, obniżając wiek uprawnionych do tego osób, bądź skracają czas między dawką trzecią a drugą.
Stella Kyriakides, fot. Twitter
20-11-2021

Commissioner Stella Kyriakides on COVID-19 and vaccination: We need to trust science! [PODCAST]

Vaccination is the most effective way to end the pandemic and get back to a normal life, says Stella Kyriakides, EU Commissioner for Health and Food Safety.
Stella Kyriakides: Strong European Health Union is the future of EU health policy
17-11-2021

Stella Kyriakides: Strong European Health Union is the future of EU health policy [INTERVIEW]

„A healthy and resilient healthcare workforce is the fundamental basis of a sustainable healthcare system. And a sustainable healthcare system is the basis not only for our well-being but also for our economies and our societies” – says Stella Kyriakides,...
covid19-pandemic-seasonal-flu-influenza-vaccination-jabs
31-10-2021

COVID-19 and seasonal flu: Will the pandemic prompt more people to get jabbed against influenza?

The ECDC has recently warned that Europe's elderly could be facing a difficult flu season, which in combination with the next pandemic wave may lead to severe health consequences.
szczepionka-malaria-afryka-who-pandemia-azja-komary-glaxosmithkline-koncerny-farmaceutyczne-gavi-Mosquirix-gates
27-10-2021

Ta szczepionka to historyczny przełom. Preparat chroniący dzieci przed malarią podawany w Afryce

Malaria co roku zabija ponad 260 tys. dzieci poniżej 5. roku życia.
coronavirus-vaccines-delta-COVID-antibodies-third-jab-moderna-pfizer-biontech-J&J-mrna-
29-09-2021

Coronavirus: Certain vaccines present more antibodies than others. Not every person will have to get a third jab?

Antibodies against coronavirus, produced by the immune system as a result of vaccination, wane over time. Recent studies have suggested, however, that this process may be happening at different rates for different COVID-19 mRNA vaccines. Scientists are wondering what this...
16-09-2021

Bartosz Arłukowicz: „Any method is good that leads to the surge in vaccinated population” [INTERVIEW]

"In vaccination, education has a key role. It is important that politicians convince the people that the vaccine is the only way to keep safe", says Bartosz Arłukowicz, MEP and former Health Minister.
coronavirus-vaccines-delta-COVID-antibodies-third-jab-moderna-pfizer-biontech-J&J-mrna-
15-09-2021
13-09-2021

Bartosz Arłukowicz: „Straszenie szczepionkami jest karygodne i niegodne polityka” [WYWIAD]

"Ludzie mają prawo mieć wątpliwości ws. szczepień. Trzeba z nimi na spokojnie rozmawiać, przekonywać, ale nie można ich wyśmiewać, czy stygmatyzować" - twierdzi Bartosz Arłukowicz.
Vaccines are not equally available everywhere in the world.
03-09-2021

Vaccine inequality may cost the world over 2 trillion dollars

The costs of vaccine inequality are massive. Will the world's richest nations act to alleviate the problem plaguing low-income countries?
szczepienia-koronawirus-pandemia-COVID-19-nierówności-WHO-USA-Niemcy-Izrael
30-08-2021

Szczepionkowe nierówności mogą kosztować świat grubo ponad 2 bln dolarów

Zdecydowana większość zaszczepionych na świecie to jednak mieszkańcy najbogatszych krajów. Ci w biedniejszych krajach wciąż czekają.
President Tsai Ing-wen recieving firs dose of taiwanese vaccine
24-08-2021

Taiwan begins rollout of its own vaccine. Will it prove successful?

Until now, the country struggled with vaccine shortage. It obtained the jabs mostly through donations by foreign countries.
szczepienia-szczepionki-koronawirus-pandemia-covid19-antyszczepionkowcy-wywiad
07-08-2021

Niechęć do szczepień to problem także wśród medyków [WYWIAD]

Musimy poważnie traktować wątpliwości części społeczeństwa co do szczepień i zrozumieć, skąd bierze się ten brak zaufania, mówi Pia Vuolanto z Instytutu Zaawansowanych Badań Społecznych Uniwersytetu Tampere.
Szczepionka
06-08-2021

Combatting vaccination mistrust requires hearing from different voices [INTERVIEW]

We are not homogeneous in our views, and the pandemic has also made people express their health choices in visible ways, says Pia Vuolanto, project coordinator of VAX-TRUST project.
children-vaccine-vaccination-polio-measles-coronavirus-pandemic-covid-unicef-who
01-08-2021

Millions of children due to COVID-19 pandemic not vaccinated against other dangerous diseases

At least 23 million children worldwide did not receive the required routine vaccinations.
BioNTech, szczepionka
29-07-2021

BioNTech works on mRNA vaccine against malaria

BioNTech plans to use its experience in working with mRNA technology to develop vaccines against malaria.
BioNTech, szczepionka
27-07-2021

BioNTech chce wyprodukować szczepionkę mRNA na malarię

Testy innowacyjnego preparatu mają rozpocząć się już w przyszłym roku. Według danych WHO w 2019 r. na całym świecie było ok. 229 mln przypadków malarii.
Building vaccine confidence
24-07-2021

Building vaccine confidence [INTERVIEW]

Overall, the key issue in vaccine hesitancy is understanding that it is not a new phenomenon, says Pia Vuolanto, Senior Research Fellow at the Tampere University Institute for Advanced Social Research and the project coordinator of the research project VAX-TRUST.